| 摘要 |
The invention relates to the use of exogenous estrogen, or a substance that causes estrogen release, in programming ovulation, measuring or controlling follicular phase length, preventing conception, facilitating fertility, therapeutically treating infertility, synchronizing early follicular phase assessments, and scheduling late follicular phase clinical evaluations.
|
